Variational autoencoder (VAE, a type of machine learning approach)-based compound designs have been reported to be beneficial in the discovery of other small molecules. Now, a team of researchers ...

A variational autoencoder (VAE) is a deep neural system that can be used to generate synthetic data. VAEs share some architectural similarities with regular neural autoencoders (AEs) but an AE is not ...

In this article, we propose a self-augmentation strategy for improving ML-based device modeling using variational autoencoder (VAE)-based techniques. These techniques require a small number of ...

As an early user of Variational AI’s technology, the Big Pharma will assess the ability of the platform to generate novel small molecules that match its target product profiles (TPPs).

Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules VANCOUVER, British Columbia–(BUSINESS WIRE)–January 25, 2024– Variational AI ...

It designs novel molecules how other generative AI foundation models like DALL-E and Midjourney create novel images based on text prompts." Kim explained that scientists who use Variational AI's ...

VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA ...

“We are pleased to announce Merck as an early-access user of our Enki™ Platform,” said Handol Kim, CEO, Variational AI. “Merck will evaluate Enki’s ability to generate novel small molecules on targets ...